Analyst Ratings for Regeneron Pharma (REGN) [Sells]
REGN Rating Summary
REGN Price Target Summary
- Highest: $1,184.00 (RBC Capital)
- Lowest: $795.00 (Cantor Fitzgerald)
- Average: $1,031.53
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$1,031.53 (+7.5%)
* Over Last 12-Mos
Rating Score: 6.7 / 10 Percentile Rank: 72%
Rating Score: 6.7 / 10 Percentile Rank: 72%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
1/5/2022 | BofA Securities » Updated 4/4/2022 |
Geoff Meacham | Downgrade | Underperform (Neutral) |
565.00 (575.00) |
616.82 (959.92) |
55.62% | Details |